Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.

BioNTech AG, a European biotechnology company that has drug-development partnerships with Pfizer Inc. and Sanofi, is weighing an initial public offering in the U.S., people familiar with the matter said.